Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Working Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Working Capital/Sales(x) 1.080.991.026.375.12

What is the latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) is 1.08 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.08
Mar20230.99
Mar20221.02
Mar20136.37
Mar20125.12

How is Working Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2024 1.08
9.09
Mar2023 0.99
-2.94
Mar2022 1.02
-83.99
Mar2013 6.37
24.41
Mar2012 5.12 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Working Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹346.1 Cr 3.8% -5.1% -11.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹17,556.0 Cr -1.8% -10% 72% Stock Analytics
KAVERI SEED COMPANY ₹4,564.2 Cr 6.1% 4.7% 42.6% Stock Analytics
VENKYS (INDIA) ₹2,399.5 Cr -1% 0.7% -14.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,518.8 Cr -2.3% -10.8% -36.8% Stock Analytics
TIERRA AGROTECH ₹402.6 Cr 2.3% 1.4% -34.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.8%

-5.1%

-11.5%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses